BM
Bristol-Myers Squibb Company
BMY · Bristol-Myers Squibb Company · Healthcare
Up next day
6/12
50%
Fell despite growth
3/12
Good earnings ignored
Avg earnings move
±2.0%
typical swing on earnings
Price when beating
-0.6%
avg over 12 beats
Biggest single move
+4.2%
'25.12 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Beating estimates doesn't always lift it
Up the next day 6 of 12 beats (50%)
vs Healthcare sector avg (153 peers)
This
-0.6%
Sector
+0.4%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
The number and guidance move the price about equally
Moved opposite to results 6 of last 12 times (50%)
6xBeat but fell
Even a beat sells off if guidance disappoints
0xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Oct 29Before open
'26.9 expectedEst. EPS $1.73
Quarter ended 6/2026
Reported 2026-07-30
Next-day move
+0.7%
After 5 days -1.1%
vs Consensus$1.60→$2.04+27.7% beat
EPS
$2.04
YoY +40%
Revenue
$13.0B
YoY +6%
Next-Q guidance
—
N/A
Price around earnings
Earnings trend · last 12 quarters
EPS$2.04YoY +40%
'23.9'26.6
Revenue$13.0BYoY +6%
'23.9'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
5x42%
Met expectations
good · up ↑
1x8%
Disappointment
weak · down ↓
3x25%
Good earnings ignored
good · down ↓
3x25%
← ← Weak earningsStrong earnings → →
Price rose even on weak earnings — bad news priced in / buy-the-dip · 5 of 12q (42%)
Community · BMY
What do you think of this stock's earnings pattern?
···